- Home
- RLMD vs LBRX Comparison
RLMD vs LBRX Comparison
Compare RLMD & LBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- LBRX
- Stock Information
- Founded
- RLMD 2004
- LBRX 2015
- Country
- RLMD United States
- LBRX United States
- Employees
- RLMD N/A
- LBRX N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- LBRX Biotechnology: Pharmaceutical Preparations
- Sector
- RLMD Health Care
- LBRX Health Care
- Exchange
- RLMD Nasdaq
- LBRX Nasdaq
- Market Cap
- RLMD 289.7M
- LBRX 337.7M
- IPO Year
- RLMD N/A
- LBRX 2025
- Fundamental
- Price
- RLMD $3.98
- LBRX $14.80
- Analyst Decision
- RLMD Hold
- LBRX Strong Buy
- Analyst Count
- RLMD 2
- LBRX 3
- Target Price
- RLMD $1.00
- LBRX $46.33
- AVG Volume (30 Days)
- RLMD 1.8M
- LBRX 89.6K
- Earning Date
- RLMD 11-13-2025
- LBRX 11-06-2025
- Dividend Yield
- RLMD N/A
- LBRX N/A
- EPS Growth
- RLMD N/A
- LBRX N/A
- EPS
- RLMD N/A
- LBRX N/A
- Revenue
- RLMD N/A
- LBRX N/A
- Revenue This Year
- RLMD N/A
- LBRX N/A
- Revenue Next Year
- RLMD N/A
- LBRX N/A
- P/E Ratio
- RLMD N/A
- LBRX N/A
- Revenue Growth
- RLMD N/A
- LBRX N/A
- 52 Week Low
- RLMD $0.24
- LBRX $13.36
- 52 Week High
- RLMD $4.34
- LBRX $20.25
- Technical
- Relative Strength Index (RSI)
- RLMD 78.00
- LBRX N/A
- Support Level
- RLMD $2.42
- LBRX N/A
- Resistance Level
- RLMD $2.86
- LBRX N/A
- Average True Range (ATR)
- RLMD 0.43
- LBRX 0.00
- MACD
- RLMD 0.15
- LBRX 0.00
- Stochastic Oscillator
- RLMD 82.19
- LBRX 0.00
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.